Intrinsic Value of S&P & Nasdaq Contact Us

Daxor Corporation DXR NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
89/100
6/7 Pass
SharesGrow Intrinsic Value
$39.98
+326.2%
Analyst Price Target
$23.00
+145.2%

Stock Statistics — DXR

Daxor Corporation (DXR) has a market capitalization of $47.26M and trades at $9.38. The 52-week range is 7.1-14.76.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 5.1, Earnings Per Share (EPS) of $1.84, annual revenue of $503.42K.

The stock has a beta of 0.14, operates in the Healthcare sector.

Trading Data
Current Price$9.38
52-Week Range7.1-14.76
Volume2.77K
Avg Volume (30D)10.74K
Market Cap$47.26M
Beta (1Y)0.14
Company
IPO Date1983-07-25
Employees37
CEOMichael Richard Feldschuh
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS2394671034
CUSIP239467103
Income (Latest Year)
Revenue$503.42K
Gross Profit$188.74K
EBITDA$9.19M
Operating Income$9.19M
Net Income$9.17M
EPS$1.84
EPS Diluted$1.84
Shares Outstanding$4.99M
Balance Sheet (Latest Year)
Total Assets$46.01M
Total Liabilities$122.6K
Total Debt$112K
Net Debt$112K
Total Equity$45.89M
Debt / Equity0.00
Valuation Ratios
P/E Ratio5.1
P/S Ratio93.88
P/B Ratio1.03
EV/EBITDA (approx)5.1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message